Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Molecules ; 26(8)2021 Apr 10.
Article in English | MEDLINE | ID: mdl-33920113

ABSTRACT

Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer's disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design and synthesis of a novel [11C]promethazine PET radioligand for future in vivo studies. The [11C]promethazine was isolated by RP-HPLC with radiochemical purity >95% and molar activity of 48 TBq/mmol. The specificity of the probe was demonstrated using human hippocampal tissues via autoradiography.


Subject(s)
Alzheimer Disease/diagnosis , Brain/diagnostic imaging , Promethazine/pharmacology , Radiopharmaceuticals/pharmacology , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology , Animals , Autoradiography , Brain/drug effects , Humans , Mice , Plaque, Amyloid/diagnosis , Plaque, Amyloid/diagnostic imaging , Plaque, Amyloid/pathology , Positron-Emission Tomography , Promethazine/chemical synthesis , Promethazine/chemistry , Radiochemistry , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/chemistry
2.
AAPS PharmSciTech ; 9(3): 1006-15, 2008.
Article in English | MEDLINE | ID: mdl-18770049

ABSTRACT

The purpose of this study was to design a 'Traveller Friendly Drug Delivery System' for PM-HCl. Conventional promethazine (PM-HCl) tablets are bitter, need to be taken 1 h before symptoms and water is also needed. Taste-masked granules were produced with Eudragit E100 by extrusion, and analyzed with FTIR, DSC, and XRD. Tablets formulated from granules by direct compression using Ac-Di-Sol, Polyplasdone-XL, Primojel and ion-exchanger Tulsion339 and evaluated for mass uniformity, friability, tensile strength, drug content uniformity, water absorption ratio, in-vitro and in-vivo disintegration time and in-vitro dissolution studies. The observed drug-polymer interactions and reduced crystallinity may be reasons for increased dissolution rates. The formulated tablets were disintegrated within 15 s. Tablets (25 mg PM-HCl) with Ac-Di-Sol (4%) showed complete release within 1 min, while marketed conventional tablets (Phenergan; Rhone-Poulec) release 25% during the same period. A preliminary stability studies for the prepared tablets carried at 30 +/- 2 degrees C/60 +/- 5% RH, and 40 +/- 2 degrees C/75 +/- 5%RH for 3 months showed no significant changes in the tablets quality at 30 +/- 2 degrees C/60 +/- 5% RH. However, at 40 +/- 2 degrees C/75 +/- 5%RH marked increase in in-vitro disintegration time, tensile strength and decrease in friability and water absorption ratio was found. The present studies indicate the abilities of Eudragit E 100 for taste masking and improving the dissolution profile of PM-HCl after complexation. In addition, by employing cost effective direct compression method, fast-dissolving tablets of 400 mg total weight with an acceptable quality could be prepared.


Subject(s)
Drug Design , Motion Sickness/prevention & control , Promethazine/administration & dosage , Promethazine/chemical synthesis , Tablets/chemical synthesis , Administration, Oral , Calorimetry, Differential Scanning , Chemistry, Pharmaceutical , Drug Stability , Hardness/drug effects , Hardness/physiology , Humans , Motion Sickness/metabolism , Powders , Promethazine/pharmacokinetics , Solubility/drug effects , Tablets/administration & dosage , Tablets/pharmacokinetics , Taste Perception/drug effects , Taste Perception/physiology
3.
Bioorg Med Chem Lett ; 17(5): 1346-8, 2007 Mar 01.
Article in English | MEDLINE | ID: mdl-17188865

ABSTRACT

Quaternized chlorpromazine, triflupromazine, and promethazine derivatives were synthesized and examined as antitubercular agents against both actively growing and non-replicating Mycobacterium tuberculosis H37Rv. Impressively, several compounds inhibited non-replicating M. tuberculosis at concentrations equal to or double their MICs against the actively growing strain. All active compounds were non-toxic toward Vero cells (IC50 > 128 microM). N-Allylchlorpromazinium bromide was only weakly antitubercular, but replacing allyl with benzyl or substituted benzyl improved potency. An electron-withdrawing substituent on the phenothiazine ring was also essential. Branching at the carbon chain decreased antitubercular activity. The optimum antitubercular structures possessed N-(4- or 3-chlorobenzyl) substitution on triflupromazine.


Subject(s)
Antitubercular Agents/chemical synthesis , Antitubercular Agents/pharmacology , Chlorpromazine/chemical synthesis , Chlorpromazine/pharmacology , Mycobacterium tuberculosis/drug effects , Promazine/chemical synthesis , Promazine/pharmacology , Promethazine/chemical synthesis , Promethazine/pharmacology , Quaternary Ammonium Compounds/chemical synthesis , Quaternary Ammonium Compounds/pharmacology , Structure-Activity Relationship , Triflupromazine/chemical synthesis , Triflupromazine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...